Open AccessFLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
Author(s) -
Patrick A. Brown,
John A. Kairalla,
Joanne M. Hilden,
ZoAnn E. Dreyer,
Andrew J. Carroll,
Nyla A. Heerema,
Cindy Wang,
Meenakshi Devidas,
Lia Gore,
Wanda L. Salzer,
Naomi Winick,
William L. Carroll,
Elizabeth A. Raetz,
Michael J. Borowitz,
Donald Small,
Mig L. Loh,
Stephen P. Hunger
Publication year - 2021
Publication title -
leukemia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-021-01177-6
Subject(s) - medicine , chemotherapy , lymphoblastic leukemia , oncology , pediatric oncology , acute lymphocytic leukemia , leukemia , clinical trial , pediatrics , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom